GlassScriptPhysician profile
Zoha Khan
NPI 1467079269
$2,567.11
in general payments reported to CMS, 2019-2025
12 companies · $397 in 2025
The $397 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.75 · 2021: $1,425 · 2022: $413 · 2023: $36.73 · 2024: $280 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $1,200.00 | 2021 | |
| Abbott Laboratories | $539.85 | 2024-2025 | Diamondback Peripheral, Esprit |
| Smith+Nephew, INC. | $206.22 | 2021-2025 | Pico 7, Renasys Go V2 Home, Grafix Pl |
| Nevro Corp. | $144.35 | 2022-2024 | Senza |
| Acera Surgical, INC. | $107.60 | 2022 | |
| Stryker Corporation | $100.40 | 2022 | |
| Paratek Pharmaceuticals, INC. | $94.50 | 2021-2025 | Nuzyra |
| Depuy Synthes Sales INC. | $91.81 | 2022 | |
| Convatec INC. | $31.29 | 2025 | |
| Kerecis Limited | $23.07 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Kci USA, INC. | $14.75 | 2020 | |
| Zimmer Biomet Holdings, INC. | $13.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zoha Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.